Cong Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Cong Zhang has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Lei Yan
Department of Urology, Qilu Hospital, Shandong University, Jinan, People’s Republic of China
2 shared publicationsChenfei Wang
1 shared publicationDawei Li
1 shared publication- Dawei Li
Department of Urology, Qilu Hospital of Shandong University, Jinan, China
1 shared publication Dongshan Chen
1 shared publication- Dongshan Chen
Department of Urology Qilu Hospital of Shandong University Jinan China
1 shared publication
Latest Publications
- 21 October 2026
- Published by Springer Nature in Surgical Endoscopy
- p. 1-12
Anatomical landmark-based proportional coordinate localization in laparoscopic partial nephrectomy for completely endophytic renal tumors
Background Accurate localization of completely endophytic renal tumors remains challenging in laparoscopic partial nephrectomy, and conventional intraoperative ultrasonography is experience-dependent. Objective To evaluate an intraoperative localization technique based on AI-assisted three-dimensional reconstruction and an anatomical landmark-based proportional coordinate system (XYZ). Methods We retrospectively analyzed 105 patients treated from May 2016 to July 2025. Patients were assigned to the XYZ coordinate-guided localization group (n = 52), using preoperative three-dimensional planning, calculation of the proportional XYZ coordinates, and intraoperative ultrasonographic verification, or the traditional localization group (n = 53), using conventional imaging and intraoperative ultrasonographic scanning. Localization efficiency, perioperative outcomes, and trifecta achievement were compared. Results Baseline characteristics were comparable. Compared with the traditional localization group, the XYZ coordinate-guided localization group had shorter localization time (225.5 s vs 317.0 s, p < 0.001), higher first-attempt localization success rate (59.62% vs 37.74%, p = 0.025), shorter warm ischemia time (21.73 min vs 27.19 min, p < 0.001), and higher trifecta achievement rate (61.54% vs 24.52%, p < 0.001). Estimated blood loss was lower (105.0 mL vs 130.0 mL, p = 0.035), blood transfusion tended to be reduced (3.85% vs 16.98%, p = 0.052), and acute kidney injury was less frequent (11.54% vs 28.30%, p = 0.032). Multivariable regression confirmed XYZ coordinate-guided localization group was associated with higher odds of achieving the trifecta and shorter warm ischemia time. Conclusion In the present study, XYZ coordinate-guided localization was associated with shorter intraoperative localization and warm ischemia times and a higher rate of achieving the trifecta than traditional localization. We will conduct prospective multicenter studies to further evaluate its effectiveness and generalizability. Graphical abstract
- 21 October 2026
- Published by Springer Nature in Surgical Endoscopy
- p. 1-12
Anatomical landmark-based proportional coordinate localization in laparoscopic partial nephrectomy for completely endophytic renal tumors
Background Accurate localization of completely endophytic renal tumors remains challenging in laparoscopic partial nephrectomy, and conventional intraoperative ultrasonography is experience-dependent. Objective To evaluate an intraoperative localization technique based on AI-assisted three-dimensional reconstruction and an anatomical landmark-based proportional coordinate system (XYZ). Methods We retrospectively analyzed 105 patients treated from May 2016 to July 2025. Patients were assigned to the XYZ coordinate-guided localization group (n = 52), using preoperative three-dimensional planning, calculation of the proportional XYZ coordinates, and intraoperative ultrasonographic verification, or the traditional localization group (n = 53), using conventional imaging and intraoperative ultrasonographic scanning. Localization efficiency, perioperative outcomes, and trifecta achievement were compared. Results Baseline characteristics were comparable. Compared with the traditional localization group, the XYZ coordinate-guided localization group had shorter localization time (225.5 s vs 317.0 s, p < 0.001), higher first-attempt localization success rate (59.62% vs 37.74%, p = 0.025), shorter warm ischemia time (21.73 min vs 27.19 min, p < 0.001), and higher trifecta achievement rate (61.54% vs 24.52%, p < 0.001). Estimated blood loss was lower (105.0 mL vs 130.0 mL, p = 0.035), blood transfusion tended to be reduced (3.85% vs 16.98%, p = 0.052), and acute kidney injury was less frequent (11.54% vs 28.30%, p = 0.032). Multivariable regression confirmed XYZ coordinate-guided localization group was associated with higher odds of achieving the trifecta and shorter warm ischemia time. Conclusion In the present study, XYZ coordinate-guided localization was associated with shorter intraoperative localization and warm ischemia times and a higher rate of achieving the trifecta than traditional localization. We will conduct prospective multicenter studies to further evaluate its effectiveness and generalizability. Graphical abstract
- Open Access
- 27 May 2022
- Published by Wiley in Journal of Oncology
- Vol. 2022, 1-13
Cell-free DNA as a Promising Diagnostic Biomarker in Prostate Cancer: A Systematic Review and Meta-Analysis
Objective. The detection of cell-free DNA (cfDNA) as a part of “liquid biopsy” of prostate cancer (PCa) has been widely explored. However, its diagnostic value for PCa remains controversial. Based on the data from the latest literature published in the past decade, the present review was conducted to clarify the diagnostic value of cfDNA in PCa. Methods. The related studies were systematically searched in the databases of PubMed, Embase, Web of Science, and Cochrane Library from January 1, 2010 to December 1, 2020. Sensitivity (SEN), specificity (SPE), and other relative parameters were pooled using a random model. Results. 14 eligible studies with 1049 PCa patients and 973 controls were selected based on the inclusion and exclusion criteria. Results demonstrated that cfDNA showed favorable SPE (0.89, 95% CI: 0.79, 0.94) but unsatisfied SEN (0.56, 95% CI: 0.43, 0.68) in the PCa diagnosis. The positive likelihood ratios (PLR), negative likelihood ratios (NLR), and diagnostic odds ratios (DOR) were 5.1 (95% CI: 3.1, 8.5), 0.49 (95% CI: 0.39, 0.63), and 10 (95% CI: 6, 17), respectively. The summary receiver operating characteristic graph (SROC) with an area under the curve (AUC) of 0.80 (95% CI: 0.76, 0.83) was constructed which indicated favorable diagnostic accuracy for PCa. Results of the subgroup analysis and metaregression analysis reminded “ethnicity” and “methylation” might be sources of heterogeneity. The potential publication bias was not found using Deek’s funnel plot asymmetry test ( ). Conclusions. Our meta-analysis illustrated that the cfDNA could undertake a promising role in the PCa diagnosis.
- 27 May 2022
- Published by Wiley in Journal of Oncology
- Vol. 2022, 1-13
Open AccessCell-free DNA as a Promising Diagnostic Biomarker in Prostate Cancer: A Systematic Review and Meta-Analysis
Objective. The detection of cell-free DNA (cfDNA) as a part of “liquid biopsy” of prostate cancer (PCa) has been widely explored. However, its diagnostic value for PCa remains controversial. Based on the data from the latest literature published in the past decade, the present review was conducted to clarify the diagnostic value of cfDNA in PCa. Methods. The related studies were systematically searched in the databases of PubMed, Embase, Web of Science, and Cochrane Library from January 1, 2010 to December 1, 2020. Sensitivity (SEN), specificity (SPE), and other relative parameters were pooled using a random model. Results. 14 eligible studies with 1049 PCa patients and 973 controls were selected based on the inclusion and exclusion criteria. Results demonstrated that cfDNA showed favorable SPE (0.89, 95% CI: 0.79, 0.94) but unsatisfied SEN (0.56, 95% CI: 0.43, 0.68) in the PCa diagnosis. The positive likelihood ratios (PLR), negative likelihood ratios (NLR), and diagnostic odds ratios (DOR) were 5.1 (95% CI: 3.1, 8.5), 0.49 (95% CI: 0.39, 0.63), and 10 (95% CI: 6, 17), respectively. The summary receiver operating characteristic graph (SROC) with an area under the curve (AUC) of 0.80 (95% CI: 0.76, 0.83) was constructed which indicated favorable diagnostic accuracy for PCa. Results of the subgroup analysis and metaregression analysis reminded “ethnicity” and “methylation” might be sources of heterogeneity. The potential publication bias was not found using Deek’s funnel plot asymmetry test ( ). Conclusions. Our meta-analysis illustrated that the cfDNA could undertake a promising role in the PCa diagnosis.
- 1 August 2020
- Published by Elsevier in Environmental Toxicology and Pharmacology
- Vol. 78, 103382
Effect of daunorubicin on acute promyelocytic leukemia cells using nuclear magnetic resonance spectroscopy-based metabolomics
- 1 August 2020
- Published by Elsevier in Environmental Toxicology and Pharmacology
- Vol. 78, 103382
Effect of daunorubicin on acute promyelocytic leukemia cells using nuclear magnetic resonance spectroscopy-based metabolomics
- Open Access
- 1 August 2019
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 11, 7909-7923
Downregulation of HDGF inhibits the tumorigenesis of bladder cancer cells by inactivating the PI3K-AKT signaling pathway
Background: Hepatoma-derived growth factor (HDGF) is a heparin-binding protein that has been observed to be abnormally expressed in numerous malignancies, but the definite role of HDGF in bladder cancer (BCa) has not been clarified. Here, we conduct the present study to evaluate correlations between HDGF and BCa. Methods: Bioinformatics analysis was used to evaluate HDGF expression levels in BCa tissues. The effect of HDGF on cell proliferation, migration, invasion, cell cycle and apoptosis was analyzed utilizing CCK-8, clone formation, Transwell assays and flow cytometry, respectively. In addition, the xenograft tumor model was established. Results: Based on bioinformatics analysis, we noticed that HDGF was highly expressed in BCa tissues and was positively correlated with poor prognosis in patients. Knockdown of HDGF markedly reduced tumorigenesis in BCa cells. Furthermore, the results of flow cytometry showed that HDGF deletion enhanced apoptosis in T24 and 253J cells and led to cell cycle arrest in G1 phase. In further studies, we found that tumor growth was inhibited in xenograft nude mouse models with HDGF deletion. The results of RNA-seq analysis revealed that the PI3K-AKT signaling pathway-related genes were obviously changed in HDGF-deficient 253J cells, and this result was further confirmed by Western blot analysis. Conclusion: In summary, we suggest that HDGF plays a substantial role in BCa and promotes tumor development and progression by regulating the PI3K-AKT signaling pathway, which provides a promising target for BCa treatment.
- 1 August 2019
- Published by Taylor & Francis in Cancer Management and Research
- Vol. ume 11, 7909-7923
Open AccessDownregulation of HDGF inhibits the tumorigenesis of bladder cancer cells by inactivating the PI3K-AKT signaling pathway
Background: Hepatoma-derived growth factor (HDGF) is a heparin-binding protein that has been observed to be abnormally expressed in numerous malignancies, but the definite role of HDGF in bladder cancer (BCa) has not been clarified. Here, we conduct the present study to evaluate correlations between HDGF and BCa. Methods: Bioinformatics analysis was used to evaluate HDGF expression levels in BCa tissues. The effect of HDGF on cell proliferation, migration, invasion, cell cycle and apoptosis was analyzed utilizing CCK-8, clone formation, Transwell assays and flow cytometry, respectively. In addition, the xenograft tumor model was established. Results: Based on bioinformatics analysis, we noticed that HDGF was highly expressed in BCa tissues and was positively correlated with poor prognosis in patients. Knockdown of HDGF markedly reduced tumorigenesis in BCa cells. Furthermore, the results of flow cytometry showed that HDGF deletion enhanced apoptosis in T24 and 253J cells and led to cell cycle arrest in G1 phase. In further studies, we found that tumor growth was inhibited in xenograft nude mouse models with HDGF deletion. The results of RNA-seq analysis revealed that the PI3K-AKT signaling pathway-related genes were obviously changed in HDGF-deficient 253J cells, and this result was further confirmed by Western blot analysis. Conclusion: In summary, we suggest that HDGF plays a substantial role in BCa and promotes tumor development and progression by regulating the PI3K-AKT signaling pathway, which provides a promising target for BCa treatment.